Participate in the event designed to make every connection meaningful, targeted, and geared towards achieving breakthroughs in biotech.

Read more

Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow's Normal’ to Patients

Read more

ESMO 2025 will be a place where groundbreaking discoveries, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care.

Read more

In a time of remarkable discovery and progress, the biotechnology industry stands at the forefront of a revolution changing how we live, heal, and care. From pioneering treatments offering hope to millions, to sustainable agricultural innovations to feed a growing population, or environmental breakthroughs securing our future, biotech drives positive change faster than ever. This progress is not just a change but a promise for a brighter future. The world is ready.

Read more

Visit Tigermed and our global experts at booth 13114. Attend the 2025 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.

Read More

Spanning 16 years, DIA China Annual Meeting has become an unparalleled feast in the life science field in Asia, like the river of life, flowing with wisdom and dreams in the whole life cycle from drug development to marketable applications.

Read More

CRM Trial Connect is sprinting towards its 4th year, with current and new collaborators on board this program! This time we are going bigger, with the theme to Accelerate Clinical Trials in Asia! Not only that, as we also have a few co-joining events taking place concurrently with this mega conference!

Read more

Join the Swiss Biotech Day to network, exchange ideas and explore advances in R&D, manufacturing, data management, AI and innovative financing. In addition, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments, public-private partnerships, R&D collaborations and the exchange of best practices.

Read more